PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy

Overview of attention for article published in International Journal of Radiation Oncology, Biology, Physics, January 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 47 news outlets
twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 33 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

METHODS AND COMPOSITIONS UTILIZING RRX-001 FOR RADIOPROTECTION

Grant EP-3737372-B1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.